Severe Nephrotoxic Nephritis following Conditional and Kidney-Specific Knockdown of Stanniocalcin-1

Background Inflammation is the hallmark of nephrotoxic nephritis. Stanniocalcin-1 (STC1), a pro-survival factor, inhibits macrophages, stabilizes endothelial barrier function, and diminishes trans-endothelial migration of leukocytes; consistently, transgenic (Tg) overexpression of STC1 protects from nephrotoxic nephritis. Herein, we sought to determine the phenotype of nephrotoxic nephritis after conditional and kidney-specific knockdown of STC1. Methods We used Tg mice that, express either STC1 shRNA (70% knockdown of STC1 within 4d) or scrambled shRNA (control) upon delivery of Cre-expressing plasmid to the kidney using ultrasound microbubble technique. Sheep anti-mouse GBM antibody was administered 4d after shRNA activation; and mice were euthanized 10 days later for analysis. Results Serum creatinine, proteinuria, albuminuria and urine output were similar 10 days after anti-GBM delivery in both groups; however, anti-GBM antibody delivery to mice with kidney-specific knockdown of STC1 produced severe nephrotoxic nephritis, characterized by severe tubular necrosis, glomerular hyalinosis/necrosis and massive cast formation, while control mice manifested mild tubular injury and crescentic glomerulonephritis. Surprisingly, the expression of cytokines/chemokines and infiltration with T-cells and macrophages were also diminished in STC1 knockdown kidneys. Staining for sheep anti-mouse GBM antibody, deposition of mouse C3 and IgG in the kidney, and antibody response to sheep IgG were equal. Conclusions nephrotoxic nephritis after kidney-specific knockdown of STC1 is characterized by severe tubular and glomerular necrosis, possibly due to loss of STC1-mediated pro-survival factors, and we attribute the paucity of inflammation to diminished release of cytokines/chemokines/growth factors from the necrotic epithelium.

[1]  L. Truong,et al.  AKI after conditional and kidney-specific knockdown of stanniocalcin-1. , 2014, Journal of the American Society of Nephrology : JASN.

[2]  Luping Huang,et al.  Overexpression of stanniocalcin-1 inhibits reactive oxygen species and renal ischemia/reperfusion injury in mice , 2012, Kidney international.

[3]  May P. Xiong,et al.  Non-cell-autonomous RNA interference in mammalian cells: Implications for in vivo cell-based RNAi delivery , 2011, Journal of RNAi and gene silencing : an international journal of RNA and gene targeting research.

[4]  V. Dixit,et al.  Mitochondrial reactive oxygen species drive proinflammatory cytokine production , 2011, The Journal of experimental medicine.

[5]  J. Cook,et al.  The mitochondrial component of intracrine action. , 2010, American Journal of Physiology. Heart and Circulatory Physiology.

[6]  F. Schena,et al.  TLR2 plays a role in the activation of human resident renal stem/progenitor cells , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  M. Abdelrahim,et al.  Stanniocalcin-1 Suppresses Superoxide Generation in Macrophages through Induction of Mitochondrial Ucp2 , 2008 .

[8]  L. Truong,et al.  Immunopathology and Infectious Diseases Anti-Inflammatory and Renal Protective Actions of Stanniocalcin-1 in a Model of Anti-Glomerular Basement Membrane Glomerulonephritis , 2010 .

[9]  Q. Yao,et al.  Human Stanniocalcin-1 Blocks TNF-&agr;–Induced Monolayer Permeability in Human Coronary Artery Endothelial Cells , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[10]  G. F. Wagner,et al.  Stanniocalcin-1 secretion and receptor regulation in kidney cells. , 2008, American journal of physiology. Renal physiology.

[11]  Matthew R. McReynolds,et al.  Stanniocalcin-1 regulates endothelial gene expression and modulates transendothelial migration of leukocytes. , 2007, American journal of physiology. Renal physiology.

[12]  Pumin Zhang,et al.  A transgenic approach for RNA interference-based genetic screening in mice , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[13]  P. Tipping,et al.  Glomerular expression of CD80 and CD86 is required for leukocyte accumulation and injury in crescentic glomerulonephritis. , 2005, Journal of the American Society of Nephrology : JASN.

[14]  C. Luo,et al.  Paracrine regulation of ovarian granulosa cell differentiation by stanniocalcin (STC) 1: mediation through specific STC1 receptors. , 2004, Molecular endocrinology.

[15]  E. Bottinger,et al.  Utility of endogenous creatinine clearance as a measure of renal function in mice. , 2004, Kidney international.

[16]  D. Etemadmoghadam,et al.  Stanniocalcin-1, an inhibitor of macrophage chemotaxis and chemokinesis. , 2004, American journal of physiology. Renal physiology.

[17]  J. Bonventre Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure. , 2003, Journal of the American Society of Nephrology : JASN.

[18]  H. Weiner,et al.  The importance of cell‐mediated immunity in the course and severity of autoimmune anti‐glomerular basement membrane disease in mice , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  G. F. Wagner,et al.  Characterization of Mammalian Stanniocalcin Receptors , 2002, The Journal of Biological Chemistry.

[20]  Jean Wu,et al.  CD4(+) T cells specific to a glomerular basement membrane antigen mediate glomerulonephritis. , 2002, The Journal of clinical investigation.

[21]  C. Blobel,et al.  Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). , 2001, The Journal of biological chemistry.

[22]  R. Hammer,et al.  Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. , 2001, Developmental biology.

[23]  M. Larsen,et al.  Stanniocalcin 1 and 2 are secreted as phosphoproteins from human fibrosarcoma cells. , 2000, The Biochemical journal.

[24]  G. F. Wagner,et al.  Development of a human stanniocalcin radioimmunoassay: serum and tissue hormone levels and pharmacokinetics in the rat , 2000, Molecular and Cellular Endocrinology.

[25]  R. Atkins,et al.  IL-1 up-regulates osteopontin expression in experimental crescentic glomerulonephritis in the rat. , 1999, The American journal of pathology.

[26]  R. Atkins,et al.  Reversal of Established Rat Crescentic Glomerulonephritis by Blockade of Macrophage Migration Inhibitory Factor (MIF): Potential Role of MIF in Regulating Glucocorticoid Production , 1998, Molecular medicine.

[27]  F. Schena Role of growth factors in acute renal failure. , 1998, Kidney international. Supplement.

[28]  T. Schall,et al.  Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion , 1997, Cell.

[29]  P. Tipping,et al.  Mechanisms of T cell‐induced glomerular injury in anti‐glomeruler basement membrane (GBM) glomerulonephritis in rats , 1997, Clinical and experimental immunology.

[30]  O. Yoshie,et al.  The T Cell-directed CC Chemokine TARC Is a Highly Specific Biological Ligand for CC Chemokine Receptor 4* , 1997, The Journal of Biological Chemistry.

[31]  H. Nomiyama,et al.  Molecular Cloning of a Novel Human CC Chemokine EBI1-ligand Chemokine That Is a Specific Functional Ligand for EBI1, CCR7* , 1997, The Journal of Biological Chemistry.

[32]  R. Atkins,et al.  The Pathogenic Role of Macrophage Migration Inhibitory Factor in Immunologically Induced Kidney Disease in the Rat , 1997, The Journal of experimental medicine.

[33]  Fadi G Lakkis,et al.  Immunologic determinants of susceptibility to experimental glomerulonephritis: role of cellular immunity. , 1997, Kidney international.

[34]  C. Martínez-A,et al.  Distinct expression and function of the novel mouse chemokine monocyte chemotactic protein-5 in lung allergic inflammation , 1996, The Journal of experimental medicine.

[35]  E. Bello‐Reuss,et al.  Expression and function of P-glycoprotein in a mouse kidney cell line. , 1995, The American journal of physiology.

[36]  J. Neugarten,et al.  Role of macrophages and colony-stimulating factor-1 in murine antiglomerular basement membrane glomerulonephritis. , 1995, Journal of the American Society of Nephrology : JASN.

[37]  M. Itô,et al.  Contribution of ED-1- and CD-8-positive cells to the development of crescentic-type anti-GBM nephritis in rats. , 1994, Nihon Jinzo Gakkai shi.

[38]  R. Atkins,et al.  The ICAM-1/LFA-1 interaction in glomerular leukocytic accumulation in anti-GBM glomerulonephritis. , 1994, Kidney international.

[39]  R. Atkins,et al.  Suppression of experimental crescentic glomerulonephritis by the interleukin-1 receptor antagonist. , 1993, Kidney international.

[40]  P. Tipping,et al.  T lymphocyte participation in antibody-induced experimental glomerulonephritis. , 1985, Kidney international.

[41]  R. Lerner,et al.  THE ROLE OF ANTI-GLOMERULAR BASEMENT MEMBRANE ANTIBODY IN THE PATHOGENESIS OF HUMAN GLOMERULONEPHRITIS , 1967, The Journal of experimental medicine.

[42]  V. Batuman,et al.  Role of proximal tubules in the pathogenesis of kidney disease. , 2011, Contributions to nephrology.

[43]  P. Tipping,et al.  Th1 responsiveness to nephritogenic antigens determines susceptibility to crescentic glomerulonephritis in mice. , 1997, Kidney international.

[44]  J. Schalkwijk,et al.  Different mediator systems in biphasic heterologous phase of anti-GBM nephritis in mice. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[45]  R. Atkins,et al.  ICAM-1 directs migration and localization of interstitial leukocytes in experimental glomerulonephritis. , 1994, Kidney international.